Janus Henderson Group
ZVSA

Janus Henderson Group’s ZyVersa Therapeutics ZVSA Stock Holding History

Janus Henderson Group’s Portfolio ZVSA Stock Details ZVSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-300
Closed -$1.05M – 2501
2022
Q3 		$1.05M Hold
300
– – ﹤0.01% 1257
2022
Q2 		$1.04M Hold
300
– – ﹤0.01% 1298
2022
Q1 		$1.04M Buy
+300
New +$1.04M ﹤0.01% 1484

Other funds holding ZVSA

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

Janus Henderson Group's ZVSA Position: Q4 2022 in Review

Janus Henderson Group sold out of ZyVersa Therapeutics (ZVSA) in Q4 2022, closing a stake of 300 shares — an estimated $1.05M sold.

Janus Henderson Group first reported a position in ZVSA in Q1 2022 and held it in 3 quarters. The position peaked at $1.05M in Q3 2022. 2 funds tracked by Wall St. Rank hold ZVSA as of Q4 2022.

  • Janus Henderson Group reported no remaining ZyVersa Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Janus Henderson Group sold 300 ZyVersa Therapeutics shares in Q4 2022, an estimated $1.05M.
  • Janus Henderson Group first reported a position in ZyVersa Therapeutics in Q1 2022 and held it in 3 quarters.
  • Janus Henderson Group's ZyVersa Therapeutics position peaked at $1.05M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held ZyVersa Therapeutics as of Q4 2022.

Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.